Indovax Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.16 Cr
as on 24-10-2024
- Company Age 38 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 55.94 Cr
as on 24-10-2024
- Satisfied Charges ₹ 10.33 Cr
as on 24-10-2024
- Revenue 2.36%
(FY 2023)
- Profit -60.23%
(FY 2023)
- Ebitda -44.10%
(FY 2023)
- Net Worth 5.08%
(FY 2023)
- Total Assets 10.47%
(FY 2023)
About Indovax
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.16 Cr.
The company currently has active open charges totaling ₹55.94 Cr. The company has closed loans amounting to ₹10.33 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Kapur, Vinod Kapur, and Deepak Kapur serve as directors at the Company.
- CIN/LLPIN
U74899DL1986PTC024582
- Company No.
024582
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 1986
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Indovax Private Limited offer?
Indovax Private Limited offers a wide range of products and services, including Veterinary Medicines, Veterinary Vaccines, FMD Vaccine, Chicken Vaccines.
Who are the key members and board of directors at Indovax?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Kapur  | Managing Director | 23-Jun-1986 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Kapur | Director | 25-Apr-2005 | Current |
| Deepak Kapur | Director | 12-May-2006 | Current |
Financial Performance and Corporate Structure Insights of Indovax.
Indovax Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.36% increase. The company also saw a substantial fall in profitability, with a 60.23% decrease in profit. The company's net worth moved up by a moderate rise of 5.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indovax?
In 2022, Indovax had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Immunetic Lifesciences Private LimitedActive 16 years 4 months
Rahul Kapur, Vinod Kapur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 Apr 2023 | ₹17.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Mar 2023 | ₹17.00 Cr | Open |
Axis Bank Limited Creation Date: 09 Mar 2021 | ₹7.00 Cr | Open |
How Many Employees Work at Indovax?
Indovax has a workforce of 251 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indovax, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indovax's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
